{"nct_id":"NCT02132429","title":"Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects","status":"TERMINATED","status_verified_date":"2015-03","start_date":"2014-05","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}